Articles - Page 35 of 69 - Drugs in Context

Management of type 2 diabetes: consensus of diabetes organizations

Elaena Quattrocchi BS, PharmD, FASHP, CDE, Tamara Goldberg BS, PharmD, BCPS, Nino Marzella BS, MS, PharmD

Article Type

Review

Published

27 Jan 2020

This article reviews the recommendations of different diabetes organizations for achieving glycemic control.

Efficacy and safety of a GABAergic drug (Gamalate® B6): effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHD

Ramón Novell MD, Susanna Esteba-Castillo PhD, Emili Rodriguez PhD

Article Type

Original Research

Published

23 Jan 2020

Gamalate B6 was evaluated in patients
with borderline intellectual functioning or mild intellectual
development disability and found to be effective and well tolerated for ADHD and challenging behavior.

Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review

Zhiheng H He MD, PhD, Yan Li MD, Nitin Trivedi MD, Sabrina Gill MD, James V Hennessey MD

Article Type

Review

Published

15 Jan 2020

Excessive exogenous thyroid hormone ingestion may lead to severe thyrotoxicosis and cause potential harm; this review of the literature suggests that thyroid hormone supplementation should not be used to alleviate nonspecific complaints in patients with normal endogenous thyroid function.